Open AccessUse of Bioresorbable Vascular Scaffold technology in treating coronary bifurcation lesions: A report about long-term clinical results and review of available literature
Author(s) -
Wael Elabbassi,
Chowdhury Ma,
Róbert Hatala
Publication year - 2019
Publication title -
bratislavské lekárske listy/bratislava medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 32
eISSN - 1336-0345
pISSN - 0006-9248
DOI - 10.4149/bll_2019_088
Subject(s) - mace , medicine , restenosis , cardiology , diabetes mellitus , conventional pci , percutaneous coronary intervention , stent , surgery , myocardial infarction , endocrinology
BVS proved safe in humans. ABSORB trials showed them performing similar to Drug Eluting Stents in simple coronary interventions. We assessed a registry of 63 patients with bifurcation lesions, treated by BVS and followed their outcomes up-to 5 years.